BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32894957)

  • 41. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum.
    Smith J; Raines G; Schneider HG
    Clin Chem Lab Med; 2018 Jan; 56(2):256-263. PubMed ID: 28787269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gamma heavy chain disease in a patient with diabetes and chronic renal insufficiency: diagnostic assessment of the heavy chain fragment.
    Lee MT; Parwani A; Humphrey R; Hamilton RG; Myers DI; Detrick B
    J Clin Lab Anal; 2008; 22(2):146-50. PubMed ID: 18348312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term renal survival of γ3-heavy chain deposition disease: a case report.
    Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S
    BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of gamma heavy chain disease using MALDI-TOF mass spectrometry.
    Thoren KL; Eveillard M; Chan P; Doddi S; Cho S; Murata K
    Clin Biochem; 2020 Mar; 77():57-61. PubMed ID: 31884198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gamma heavy chain disease screening showing a discrepancy between electrophoretic and nephelometric determinations of serum gamma globulin concentration.
    Takatani T; Morita K; Takaoka N; Tatsumi M; Okuno Y; Masutani T; Murakawa K; Fukui A; Tsukaguchi N; Okamoto Y
    Ann Clin Biochem; 2002 Sep; 39(Pt 5):531-3. PubMed ID: 12227865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A case report: isolated a heavy chain monoclonal gammopathy in a patient with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin change syndrome.
    Kim SK; Park IK; Park BH; Park W; Lee HS; Kim TH; Jun JB; Bae SC; Yoo DH; Uhm WS
    Int J Clin Pract Suppl; 2005 Apr; (147):26-30. PubMed ID: 15875614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Huge discrepancy between serum immunoglobulin concentration and proteinemia due to heavy chain disease.
    Feugray G; Fontaine C; Lanic H; Guillerme J; Quillard Muraine M
    Clin Biochem; 2022 Oct; 108():10-13. PubMed ID: 35779576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Free fragments of gamma chain in the urine. A possible source of confusion with gamma heavy-chain disease.
    Charles EZ; Valdes AJ
    Am J Clin Pathol; 1994 Apr; 101(4):462-4. PubMed ID: 8160637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune subtraction for improved resolution in serum protein immunofixation electrophoresis and antibody isotype determination in a patient with autoantibody.
    Ullah A; Omar N; Savage NM; Bollag RJ; Singh G
    Pract Lab Med; 2021 Aug; 26():e00240. PubMed ID: 34124325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunofixation in agarose gel for the identification of monoclonal immunoglobulins].
    Potdevin F; Roncato M; Drupt F; Paris M; Leclerc M
    Ann Immunol (Paris); 1983; 134C(1):105-23. PubMed ID: 6407384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The diverse picture of gamma heavy-chain disease. Report of seven cases and review of literature.
    Kyle RA; Greipp PR; Banks PM
    Mayo Clin Proc; 1981 Jul; 56(7):439-51. PubMed ID: 6789012
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of immunoglobulin heavy- and light-chain measurements compared with existing techniques as a means of typing monoclonal immunoglobulins.
    Whicher JT; Wallage M; Fifield R
    Clin Chem; 1987 Oct; 33(10):1771-3. PubMed ID: 3117430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gamma heavy chain disease associated with Hodgkin's disease. Clinical, pathologic, and immunologic features of one case.
    Di Benedetto G; Cataldi A; Verde A; Gloghini A; Nicolò G; Pistoia V
    Cancer; 1989 May; 63(9):1804-9. PubMed ID: 2495168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of a gamma heavy chain disease in a patient followed-up for a lymphoplasma cell proliferative disorder.
    Humeau C; Monjanel H; Schellenberg F
    Ann Biol Clin (Paris); 2016 Jun; 74(3):338-40. PubMed ID: 27237805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic arthritis and gamma heavy chain disease: coincidence or pathogenic link?
    Husby G; Blichfeldt P; Brinch L; Brandtzaeg P; Mellbye OJ; Sletten K; Stenstad T
    Scand J Rheumatol; 1998; 27(4):257-64. PubMed ID: 9751465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inability of a monoclonal anti-light chain antibody to detect clonal plasma cells in a patient with multiple myeloma by multicolor flow cytometry.
    van Velzen JF; van den Blink D; Bloem AC
    Cytometry B Clin Cytom; 2013; 84(1):30-2. PubMed ID: 23019187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma.
    Butch AW; Badros A; Desikan KR; Munshi NC
    Bone Marrow Transplant; 2001 Mar; 27(6):663-6. PubMed ID: 11319600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A case of Franklin disease--gamma heavy chain disease].
    von Baehr R; Schwenke H
    Z Gesamte Inn Med; 1975 Jan; 30(1):28-31. PubMed ID: 817523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid typing of serum paraproteins by immunoblotting without antigen-excess artifacts.
    Norden AG; Fulcher LM; Heys AD
    Clin Chem; 1987 Aug; 33(8):1433-6. PubMed ID: 3111752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis of gamma heavy-chain disease.
    Albutt EC; Hawker PC; Hine KR; Northam BE
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):207-10. PubMed ID: 6792974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.